Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD known ✓ | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CG known ✓ | P48736 | 1/20 | 0.34 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 10/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 10/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL7400730 | 1.00 | POLB (0.36) | POLBHCRTR1HCRTR2RECQLSMN1; SMN2 | |
| SCHEMBL7399465 | 0.96 | RECQL (0.38) | POLBHCRTR1HCRTR2RECQLSMN1; SMN2 | |
| Maleic Acid SCHEMBL7392185 | 0.83 | HCRTR1 (0.36) | HCRTR1HCRTR2PIK3CDPIK3CGOPRK1 | |
| Fumaric Acid SCHEMBL7392191 | 0.83 | HCRTR1 (0.36) | HCRTR1HCRTR2PIK3CDPIK3CGOPRK1 | |
| Maleic Acid SCHEMBL7399487 | 0.82 | KDM1A (0.38) | HCRTR1HCRTR2SMN1; SMN2TSHRKMT2A | |
| Fumaric Acid SCHEMBL7399492 | 0.81 | HCRTR1 (0.33) | HCRTR1HCRTR2OPRK1KMT2A | |
| Maleic Acid SCHEMBL7399489 | 0.81 | HCRTR1 (0.33) | HCRTR1HCRTR2OPRK1KMT2A | |
| Maleic Acid SCHEMBL7398825 | 0.81 | SMN1; SMN2 (0.35) | HCRTR1HCRTR2SMN1; SMN2TSHRALDH1A1 | |
| Fumaric Acid SCHEMBL7398829 | 0.81 | SMN1; SMN2 (0.35) | HCRTR1HCRTR2SMN1; SMN2TSHRALDH1A1 | |
| Fumaric Acid SCHEMBL7400191 | 0.80 | ACKR3 (0.40) | POLBHCRTR1HCRTR2PIK3CDPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0972773-A1 | 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates | GLAXO GROUP LIMITED (GB) | 2000-01-19 | — | — | EP | disclosed |
| US-5618827-A | TREATING GASTROINTESTINAL, URINARY, CARDIOVASCULAR, CENTRAL NERVOUS SYTEM DISORDERS | GLAXO GROUP LIMITED (GB) | 1997-04-08 | — | — | US | disclosed |
| EP-0640081-A1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1995-03-01 | — | — | EP | disclosed |
| WO-1993020071-A1 | SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1993-10-14 | — | — | WO | disclosed |